Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension
Marius M. Hoeper(Medizinische Hochschule Hannover), Jürgen Behr(Universität Hamburg), Hanno Leuchte(Universität Hamburg), Roland Wensel(Medizinische Hochschule Hannover), Michael Halank(University Hospital Carl Gustav Carus), Stefan Kluge(Universität Hamburg), F. Joachim Meyer(Heidelberg University), Hans-Juergen Seyfarth(Leipzig University), H. J. Bremer(Universität Hamburg), Heinrike Wilkens(Saarland University), F. Ripken(Medizinische Hochschule Hannover), Gert Hoeffken(Medizinische Hochschule Hannover)
Cited by 289
Related Papers
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
|Annals of Internal Medicine|2020|2.4k
Multiorgan and Renal Tropism of SARS-CoV-2
|New England Journal of Medicine|2020|1.9k
Definitions and Diagnosis of Pulmonary Hypertension
|Journal of the American College of Cardiology|2013|1.8k